Cefdinir and Methylphenidate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Methylphenidate (methylphenidate). Common drug interactions include neuropathy peripheral among females and adverse event among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Methylphenidate. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.



On Jul, 15, 2026

28 people who take Cefdinir and Methylphenidate together, and have interactions are studied.

Cefdinir and Methylphenidate drug interactions.

What are the common drug interactions of Cefdinir and Methylphenidate, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Cataract (clouding of the lens inside the eye)
  3. Cough
  4. Drug hypersensitivity
  5. Stress urinary incontinence (leak urine with things like coughing, sneezing or exercise)
  6. Infusion site pruritus (severe itching at infusion site)
  7. Pneumonia
  8. Pruritus (severe itching of the skin)
  9. Upper respiratory tract infection
  10. Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)

male:

  1. Adverse event
  2. Anxiety
  3. Headache (pain in head)
  4. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  5. Drug hypersensitivity
  6. Impulsive behaviour
  7. Irritability
  8. Peripheral swelling
  9. Troponin i increased
  10. Back injury

What are the common drug interactions of Cefdinir and Methylphenidate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Troponin i increased
  2. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  3. Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
  4. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

10-19:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

20-29:

  1. Anxiety
  2. Depression
  3. Hypersensitivity
  4. Pain
  5. Tendonitis (a condition that causes pain and swelling of tendons)

30-39:

  1. Aphonia (inability to produce voice)
  2. Blood glucose increased
  3. Cough
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Insomnia (sleeplessness)
  8. Nausea (feeling of having an urge to vomit)
  9. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  10. Restlessness (not able to rest)

40-49:

  1. Anxiety
  2. Asthma
  3. Back injury
  4. Bankruptcy
  5. Blood cholesterol increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Chest pain
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Cough

50-59:

  1. Dry eye (lack of adequate tears)
  2. Fibromyalgia (a long-term condition which causes pain all over the body)
  3. Neuropathy peripheral (surface nerve damage)
  4. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  5. Restless legs syndrome (a powerful urge to move your legs)
  6. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  7. Connective tissue disorder (any disease that has the connective tissues of the body)
  8. Swelling

60+:

  1. Cataract (clouding of the lens inside the eye)
  2. Cough
  3. Upper respiratory tract infection
  4. Abdominal pain lower
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Diarrhoea
  7. Dysphonia (speech disorder attributable to a disorder of phonation)
  8. Migraine (headache)
  9. Pneumonia
  10. Adverse drug reaction

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 57.14%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 42.86%
  3. Immunodeficiency Common Variable: 5 people, 17.86%
  4. Nausea (feeling of having an urge to vomit): 3 people, 10.71%
  5. Drowsiness: 3 people, 10.71%
  6. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 10.71%
  7. Pharyngitis Streptococcal (inflammation of the pharynx caused by infection from. streptococcus): 2 people, 7.14%
  8. Nausea And Vomiting: 2 people, 7.14%
  9. Hypersensitivity: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Methylphenidate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefdinir and Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylphenidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and methylphenidate (the active ingredients of Cefdinir and Methylphenidate, respectively), and Cefdinir and Methylphenidate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: